These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 9861319

  • 1. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose-dexamethasone suppression test.
    Mu YM, Takayanagi R, Imasaki K, Ohe K, Ikuyama S, Yanase T, Nawata H.
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):301-6. PubMed ID: 9861319
    [Abstract] [Full Text] [Related]

  • 2. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T, Hara Y, Takekoshi S, Teramoto A, Osamura RY, Tagawa M.
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Synthesis and release of CRF and ACTH in ectopic CRF/ACTH-producing tumors].
    Suda T.
    Nihon Naibunpi Gakkai Zasshi; 1994 Jan 20; 70(1):17-24. PubMed ID: 7958079
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A.
    J Clin Endocrinol Metab; 1998 May 20; 83(5):1619-23. PubMed ID: 9589666
    [Abstract] [Full Text] [Related]

  • 7. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
    Comtois R, Beauregard H, Hardy J, Robert F, Somma M.
    Clin Endocrinol (Oxf); 1993 Jun 20; 38(6):601-7. PubMed ID: 8392915
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P, Boccardi E, Branca V, Bramerio M, Barberis M, Losa M, Terreni MT, Lodrini S, Pollo B, Vignati F.
    Clin Endocrinol (Oxf); 1998 Oct 20; 49(4):433-9. PubMed ID: 9876339
    [Abstract] [Full Text] [Related]

  • 9. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N, Diederich S, Oelkers W.
    Clin Endocrinol (Oxf); 1998 Jan 20; 48(1):45-51. PubMed ID: 9509067
    [Abstract] [Full Text] [Related]

  • 10. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 2003 Nov 20; 88(11):5299-306. PubMed ID: 14602765
    [Abstract] [Full Text] [Related]

  • 11. The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.
    Reimondo G, Paccotti P, Minetto M, Termine A, Stura G, Bergui M, Angeli A, Terzolo M.
    Clin Endocrinol (Oxf); 2003 Jun 20; 58(6):718-24. PubMed ID: 12780748
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC, Raff H, Findling JW.
    J Clin Endocrinol Metab; 1997 Jun 20; 82(6):1780-5. PubMed ID: 9177382
    [Abstract] [Full Text] [Related]

  • 13. CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
    Grossman AB, Howlett TA, Perry L, Coy DH, Savage MO, Lavender P, Rees LH, Besser GM.
    Clin Endocrinol (Oxf); 1988 Aug 20; 29(2):167-78. PubMed ID: 2854761
    [Abstract] [Full Text] [Related]

  • 14. Proopiomelanocortin, glucocorticoid, and CRH receptor expression in human ACTH-secreting pituitary adenomas.
    Cassarino MF, Sesta A, Pagliardini L, Losa M, Lasio G, Cavagnini F, Pecori Giraldi F.
    Endocrine; 2017 Mar 20; 55(3):853-860. PubMed ID: 27220856
    [Abstract] [Full Text] [Related]

  • 15. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
    Morris DG, Kola B, Borboli N, Kaltsas GA, Gueorguiev M, McNicol AM, Ferrier R, Jones TH, Baldeweg S, Powell M, Czirják S, Hanzély Z, Johansson JO, Korbonits M, Grossman AB.
    J Clin Endocrinol Metab; 2003 Dec 20; 88(12):6080-7. PubMed ID: 14671214
    [Abstract] [Full Text] [Related]

  • 16. Glucocorticoid receptors and Cushing's disease.
    Lamberts SW.
    Mol Cell Endocrinol; 2002 Nov 29; 197(1-2):69-72. PubMed ID: 12431798
    [Abstract] [Full Text] [Related]

  • 17. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB, Turner HE, Adams CB, Wass JA.
    Clin Endocrinol (Oxf); 2002 Jan 29; 56(1):25-31. PubMed ID: 11849243
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas.
    Pereda MP, Lohrer P, Kovalovsky D, Perez Castro C, Goldberg V, Losa M, Chervín A, Berner S, Molina H, Stalla GK, Renner U, Arzt E.
    Exp Clin Endocrinol Diabetes; 2000 Jan 29; 108(3):202-7. PubMed ID: 10926317
    [Abstract] [Full Text] [Related]

  • 19. Cushing's syndrome with a large pituitary adenoma producing both corticotropin-releasing hormone (CRH) and adrenocorticotropin (ACTH).
    Yamada Y, Ohashi A, Inoue T, Sakaguchi K, Tsujimura T, Okamoto D, Itatani H, Fujimoto N, Kusaka K, Fushimi H.
    Intern Med; 2002 Jul 29; 41(7):549-54. PubMed ID: 12132523
    [Abstract] [Full Text] [Related]

  • 20. Human TRH receptor messenger ribonucleic acid levels in normal and adenomatous pituitary: analysis by the competitive reverse transcription polymerase chain reaction method.
    Kaji H, Xu Y, Takahashi Y, Abe H, Tamaki N, Chihara K.
    Clin Endocrinol (Oxf); 1995 Mar 29; 42(3):243-8. PubMed ID: 7758228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.